非小细胞性,Non-small cells
1)Non-small cells非小细胞性
2)non-small cell lung cancer非小细胞性肺癌
1.The in situ analysis of cytokine mRNA expression in immunological microenvironment about non-small cell lung cancer;非小细胞性肺癌局部免疫微环境中细胞因子mRNA表达的分析
2.Objective To investigate the normal range of serum CYFRA21-1 levels in local sabjects and the lower limit for the establishment of diagnosis in patients with non-small cell lung cancer.方法:采用免疫放射分 析,分析了90例健康人和58例肺良性疾病及42例非小细胞性肺癌患者血清CYFRA21-1的含量。
3)NSCLC非小细胞性肺癌
1.Objectives:Lung cancer includes non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).目的:肺癌可分为非小细胞性肺癌(NSCLC)和小细胞性肺癌(SCLC)。
2.Objective:To analyze the aberrant promoter hypermethylation of Runx3 gene in human non-small cell lung carcinoma(NSCLC).目的:分析非小细胞性肺癌(NSCLC)中Runx3基因启动子区甲基化状态。
4)non small cell非小细胞
1.CD_4~+CD_(25)~+ regulatory T cells in peripheral blood from patients with non small cell lung cancer;非小细胞肺癌患者外周血CD_4~+CD_(25)~+调节T细胞的检测及其临床意义
2.Purpose To investigate the relationship between CD44v6 expression and clinicopathologic characteristics in non small cell lung carcinomas (NSCLC).目的 探讨CD4 4v6表达与非小细胞肺癌临床病理特征之间的关系。
3.To investigate the efficacy and toxicity of combination chemotherapy with or without TAM in treatment of non small cell lung cancer.[目的]探讨全身化疗加或不加三苯氧胺对非小细胞肺癌(NSCLC)的疗效及毒性变化。
英文短句/例句

1.hsa-miR-125a-5p Enhances Invasion Ability in Non-Small Lung Carcinoma Cell Lineshsa-miR-125a-5p促进非小细胞肺癌细胞侵袭
2.Gifitinib in the Treatment for 22 Cases with Advanced Non-small Cell Lung Cancer吉非替尼治疗22例晚期非小细胞肺癌
3.Research on Expression of CXCR4 in Non Small Cell Lung Cancer Cells;CXCR4在非小细胞肺癌细胞中的表达和意义
4.Differential Expression of ASPP1 and ASPP2 in Non-small-cell Lung Cancer Cell Lines;非小细胞肺癌细胞株ASPP1和ASPP2表达的检测
5.Treatment of Advanced Non-small Cell Lung Cancer by Chemotherapy Combined with Autologous Cytokine-induced Killer Cells;自体CIK细胞联合化疗治疗晚期非小细胞肺癌
6.Role on Proliferation and Invasion Potentiality of Wnt5a in Non-Small Cell Lung Cancer;Wnt5a对非小细胞肺癌细胞增殖及侵袭潜能的影响
7.An Experimental Study on T Lymphocyte Killing by Non-small-cell Lung Cancer Cells;非小细胞肺癌反杀伤T淋巴细胞的实验研究
8.The Studies on RNA Interference iASPP Gene in NSCLC Cell LinesRNA干扰非小细胞肺癌细胞iASPP基因表达的研究
9.Expression of Wip1 in non small cell lung cancer tissue and cellsWip1在非小细胞肺癌组织及细胞中的表达
10.Subcellular localization of survivin in non-small cell lung cancer非小细胞肺癌中survivin亚细胞定位的相关研究
11.Distribution and expression of bone morphogenetic protein and activin membrane-bound inhibitor in non-small-cell lung cancer cell lineBAMBI在非小细胞肺癌细胞系中的分布及表达
12.Expression and significance of CD4~+CD25~(high) regulatory T cells in patients with non-small-cell lung cancerCD4~+CD25~(high) Tr细胞在非小细胞肺癌中的表达及意义
13.Radiosensitizing effect of trichostatin A (TSA) on non-small cell lung cancer A549 cellsTSA对非小细胞肺癌A549细胞放疗增敏性的研究
14.The Isolation and Culture of Dendritic Cells Derived from EMPE in Nsclc非小细胞肺癌EMPE来源树突状细胞的分离培养
15.Study on the CD4~+CD25~+FoxP3~+ Regulatory Cells in Peripheral Blood of NSCLC Patients非小细胞肺癌外周血CD4~+CD25~+FoxP3~+调节T细胞分析
16.The Study of CD44s Expression of Lung Cancer Cells and Peripheral Blood Lymphocytes in NSCLC;非小细胞肺癌病人外周血淋巴细胞及肺癌细胞CD44s的表达研究
17.Effects of compound rhizoma smilacinus granule on the expression of P53 gene in A549 cell lines and cell cycle of non-small cell lung cancer复方菝葜颗粒对非小细胞肺癌A549细胞P53基因、细胞周期的影响
18.Expression Difference of Survivin in Cytoplasm and Nucleus in Non-small Cell Lung Cancer and its Prognostic SignificanceSurvivin在非小细胞肺癌细胞胞质和胞核的不同表达及其预后意义
相关短句/例句

non-small cell lung cancer非小细胞性肺癌
1.The in situ analysis of cytokine mRNA expression in immunological microenvironment about non-small cell lung cancer;非小细胞性肺癌局部免疫微环境中细胞因子mRNA表达的分析
2.Objective To investigate the normal range of serum CYFRA21-1 levels in local sabjects and the lower limit for the establishment of diagnosis in patients with non-small cell lung cancer.方法:采用免疫放射分 析,分析了90例健康人和58例肺良性疾病及42例非小细胞性肺癌患者血清CYFRA21-1的含量。
3)NSCLC非小细胞性肺癌
1.Objectives:Lung cancer includes non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).目的:肺癌可分为非小细胞性肺癌(NSCLC)和小细胞性肺癌(SCLC)。
2.Objective:To analyze the aberrant promoter hypermethylation of Runx3 gene in human non-small cell lung carcinoma(NSCLC).目的:分析非小细胞性肺癌(NSCLC)中Runx3基因启动子区甲基化状态。
4)non small cell非小细胞
1.CD_4~+CD_(25)~+ regulatory T cells in peripheral blood from patients with non small cell lung cancer;非小细胞肺癌患者外周血CD_4~+CD_(25)~+调节T细胞的检测及其临床意义
2.Purpose To investigate the relationship between CD44v6 expression and clinicopathologic characteristics in non small cell lung carcinomas (NSCLC).目的 探讨CD4 4v6表达与非小细胞肺癌临床病理特征之间的关系。
3.To investigate the efficacy and toxicity of combination chemotherapy with or without TAM in treatment of non small cell lung cancer.[目的]探讨全身化疗加或不加三苯氧胺对非小细胞肺癌(NSCLC)的疗效及毒性变化。
5)non-small cell非小细胞
1.Detection of phosphorylated AKT expression and cell proliferation in non-small cell lung cancer tissue;非小细胞肺癌组织中磷酸化AKT的表达与细胞增殖检测
2.HIF-1α,GLUT1 expression in non-small cell lung cancer (NSCLC) and their association with COX-2;非小细胞肺癌中HIF-1α、GLUT1与COX-2表达的关系
3.Expression of PTTG in non-small cell lung cancer and its relationship with PTEN and Ki-67 proteins expression;非小细胞肺癌中PTTG的表达及其与PTEN和Ki67蛋白表达的关系
6)non-small-cell非小细胞
1.US NCCN (The National Comprehensive Cancer Network) clinical practice guidelines in oncology issued the second edition treatment programs for non-small-cell lung cancer in 2006.美国NCCN肿瘤学临床实践指南在2006年发布了第二版非小细胞肺癌治疗方案,对于规范化治疗肺癌以及提高肺癌病人生存率和生存质量有着积极的意义。
2.Primary lung cancer is the leading cause of cancer deaths in most industrialized countries, and non-small-cell lung cancer (NSCLC) accounts for 75-80% of primary lung cancer, and is refractory to conventional therapeutic modalities.原发性肺癌在许多工业化国家是主要的癌症死亡原因,其中非小细胞肺癌(NSCLC)占75~80%,并且用常规疗法很难治愈。
延伸阅读

连续性与非连续性(见间断性与不间断性)连续性与非连续性(见间断性与不间断性)continuity and discontinuity 11an父ux泊g四f“山。麻以角g、.连续性与非连续性(c。nt,n琳t:nuity一)_见间断性与不间断性。and diseo红ti-